biospecimen_aliquot__bcr_aliquot_barcode	tcga-a8-a093-01a-11w-a019-09
biospecimen_aliquot__bcr_aliquot_uuid	8f64ba22-0958-4fdb-8161-f83cfe57c95d
biospecimen_aliquot__bcr_patient_uuid	02f5ae33-a563-4ecb-9e33-dfa500a44931
biospecimen_aliquot__bcr_sample_barcode	tcga-a8-a093-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0099034604
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.50
biospecimen_aliquot__date_of_shipment	2010-06-29
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	6
biospecimen_aliquot__plate_id	a019
biospecimen_aliquot__plate_row	h
biospecimen_aliquot__quantity	40.00
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	80.00
biospecimen_analyte__analyte_type	repli-g (qiagen) dna
biospecimen_analyte__analyte_type_id	w
biospecimen_analyte__bcr_analyte_barcode	tcga-a8-a093-01a-11w
biospecimen_analyte__bcr_analyte_uuid	f102dec2-8c58-4dba-81b5-2547b67f4553
biospecimen_analyte__bcr_patient_uuid	02f5ae33-a563-4ecb-9e33-dfa500a44931
biospecimen_analyte__bcr_sample_barcode	tcga-a8-a093-01a
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-a8-a093
biospecimen_diagnostic_slides__bcr_patient_uuid	02f5ae33-a563-4ecb-9e33-dfa500a44931
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-a8-a093-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	1c8056d1-11cd-482d-9a23-3a9d1b4e63f0
biospecimen_normal_control__bcr_patient_barcode	tcga-a8-a093
biospecimen_normal_control__bcr_patient_uuid	02f5ae33-a563-4ecb-9e33-dfa500a44931
biospecimen_portion__bcr_patient_uuid	02f5ae33-a563-4ecb-9e33-dfa500a44931
biospecimen_portion__bcr_portion_barcode	tcga-a8-a093-01a-11
biospecimen_portion__bcr_portion_uuid	71744dff-1530-4d93-83d8-06f78b30a534
biospecimen_portion__bcr_sample_barcode	tcga-a8-a093-01a
biospecimen_portion__date_of_creation	2010-06-08
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	11
biospecimen_portion__portion_sequence	1
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-a8-a093-01a-11w
biospecimen_protocol__bcr_patient_uuid	02f5ae33-a563-4ecb-9e33-dfa500a44931
biospecimen_protocol__bcr_sample_barcode	tcga-a8-a093-01a
biospecimen_sample__bcr_patient_uuid	02f5ae33-a563-4ecb-9e33-dfa500a44931
biospecimen_sample__bcr_sample_barcode	tcga-a8-a093-01a
biospecimen_sample__bcr_sample_uuid	7b2cc917-cd91-486b-bb9b-4c57cf4e86e0
biospecimen_sample__days_to_collection	422
biospecimen_sample__initial_weight	100
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	false
biospecimen_sample__pathology_report_file_name	tcga-a8-a093.9dcf000d-d996-49a6-950a-0cd1e90cc6c7.pdf
biospecimen_sample__pathology_report_uuid	9dcf000d-d996-49a6-950a-0cd1e90cc6c7
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_slide__bcr_patient_uuid	02f5ae33-a563-4ecb-9e33-dfa500a44931
biospecimen_slide__bcr_sample_barcode	tcga-a8-a093-01a
biospecimen_slide__bcr_slide_barcode	tcga-a8-a093-01a-01-bs1
biospecimen_slide__bcr_slide_uuid	3909d441-2e91-4182-ad97-9e55853961a9
biospecimen_slide__image_file_name	tcga-a8-a093-01a-01-bs1.3909d441-2e91-4182-ad97-9e55853961a9.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	10
biospecimen_slide__percent_monocyte_infiltration	0
biospecimen_slide__percent_necrosis	1
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	59
biospecimen_slide__percent_stromal_cells	0
biospecimen_slide__percent_tumor_cells	40
biospecimen_slide__percent_tumor_nuclei	60
biospecimen_slide__section_location	bottom
biospecimen_tumor_sample__bcr_patient_barcode	tcga-a8-a093
biospecimen_tumor_sample__bcr_patient_uuid	02f5ae33-a563-4ecb-9e33-dfa500a44931
clinical_drug__bcr_drug_barcode	tcga-a8-a093-d37755
clinical_drug__bcr_drug_uuid	53987c58-785e-4e57-b53f-0cbd9c1c3579
clinical_drug__bcr_patient_barcode	tcga-a8-a093
clinical_drug__bcr_patient_uuid	02f5ae33-a563-4ecb-9e33-dfa500a44931
clinical_drug__clinical_trial_drug_classification	n/a
clinical_drug__form_completion_date	2012-12-6
clinical_drug__pharmaceutical_therapy_drug_name	tamoxifen
clinical_drug__pharmaceutical_therapy_type	hormone therapy
clinical_drug__pharmaceutical_tx_ongoing_indicator	yes
clinical_drug__pharmaceutical_tx_started_days_to	28
clinical_drug__tx_on_clinical_trial	no
clinical_follow_up__bcr_followup_barcode	tcga-a8-a093-f40555
clinical_follow_up__bcr_followup_uuid	376223f3-2a05-4951-b83b-c798ff047dfd
clinical_follow_up__bcr_patient_barcode	tcga-a8-a093
clinical_follow_up__bcr_patient_uuid	02f5ae33-a563-4ecb-9e33-dfa500a44931
clinical_follow_up__followup_lost_to	no
clinical_follow_up__form_completion_date	2013-2-23
clinical_follow_up__last_contact_days_to	546
clinical_follow_up__new_tumor_event_dx_indicator	no
clinical_follow_up__pharmaceutical_tx_adjuvant	yes
clinical_follow_up__radiation_treatment_adjuvant	yes
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_omf__bcr_omf_barcode	tcga-a8-a093-o12203
clinical_omf__bcr_omf_uuid	2ccaad0d-57a4-4250-ac42-031efd0c716b
clinical_omf__bcr_patient_barcode	tcga-a8-a093
clinical_omf__bcr_patient_uuid	02f5ae33-a563-4ecb-9e33-dfa500a44931
clinical_omf__days_to_surgical_resection	-6971
clinical_omf__drug_tx_indicator	no
clinical_omf__form_completion_date	2011-5-25
clinical_omf__malignancy_type	prior malignancy
clinical_omf__other_malignancy_anatomic_site	kidney
clinical_omf__other_malignancy_histological_type	other, specify
clinical_omf__other_malignancy_histological_type_text	malignant neoplasm of kidney, except renal pelvis
clinical_omf__radiation_tx_indicator	no
clinical_patient__age_at_diagnosis	61
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n0
clinical_patient__ajcc_pathologic_tumor_stage	stage iia
clinical_patient__ajcc_staging_edition	6th
clinical_patient__ajcc_tumor_pathologic_pt	t2
clinical_patient__anatomic_neoplasm_subdivision	right
clinical_patient__bcr_patient_barcode	tcga-a8-a093
clinical_patient__bcr_patient_uuid	02f5ae33-a563-4ecb-9e33-dfa500a44931
clinical_patient__birth_days_to	-22373
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_status_by_ihc	positive
clinical_patient__first_surgical_procedure_other	surgical resection
clinical_patient__form_completion_date	2011-5-27
clinical_patient__gender	female
clinical_patient__her2_fish_status	negative
clinical_patient__her2_ihc_score	1+
clinical_patient__her2_status_by_ihc	negative
clinical_patient__histological_type	infiltrating ductal carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	yes
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8500/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2009
clinical_patient__last_contact_days_to	546
clinical_patient__margin_status	negative
clinical_patient__menopause_status	post (prior bilateral ovariectomy or >12 mo since lmp with no prior hysterectomy)
clinical_patient__patient_id	a093
clinical_patient__pr_status_by_ihc	positive
clinical_patient__prospective_collection	no
clinical_patient__retrospective_collection	yes
clinical_patient__surgical_procedure_first	other
clinical_patient__tissue_source_site	a8
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
clinical_radiation__bcr_patient_barcode	tcga-a8-a093
clinical_radiation__bcr_patient_uuid	02f5ae33-a563-4ecb-9e33-dfa500a44931
clinical_radiation__bcr_radiation_barcode	tcga-a8-a093-r38155
clinical_radiation__bcr_radiation_uuid	a04e3037-0795-4c6c-8bd3-d7c3fb72af9b
clinical_radiation__form_completion_date	2012-12-11
clinical_radiation__radiation_adjuvant_units	gy
clinical_radiation__radiation_therapy_ended_days_to	59
clinical_radiation__radiation_therapy_ongoing_indicator	no
clinical_radiation__radiation_therapy_site	primary tumor field
clinical_radiation__radiation_therapy_started_days_to	28
clinical_radiation__radiation_therapy_type	external
clinical_radiation__treatment_best_response	complete response
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-A8-A093-01A-11W-A019-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-A8-A093-01A-11W-A019-09.bed.meta
manually_curated__id	tcga-a8-a093-01a-11w-a019-09
manually_curated__md5sum	752161a27cd08802804b8588aa238fd1
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	8f64ba22-0958-4fdb-8161-f83cfe57c95d
manually_curated__tumor_tag	brca
